Skip to main content

Contribution to prevention of mother to child transmission of HIV

Objective

Our aim is to develop protein/peptide formulation for vaccines against HIV. The overall strategy is to take advantage of immunomudulatory effects of the mandatory BCG immunisation, to co-deliver HIV-antigens to enhance antiviral immune responses. To the knowledge, this approach is totally innovative and potentially very powerful as it represents a shortcut in the delivery of the vaccine, thereby avoiding many difficulties present in African countries. Our goals are to reduce disease progression in women of childbearing age and to prevent mother to child transmission of HIV. These steps are critical to preventing a social disaster in western Africa that will impact on national, regional and global scales.

Call for proposal

FP6-2002-MOBILITY-11
See other projects for this call

Funding Scheme

ERG - Marie Curie actions-European Re-integration Grants

Coordinator

UNIVERSITY OF ROME TOR VERGATA
Address
Via Orazio Raimondo 18
Rome
Italy